Absci Corporation
NASDAQ:ABSI
3.01 (USD) • At close December 24, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Absci Corporation |
Symbool | ABSI |
Munteenheid | USD |
Prijs | 3.01 |
Beurswaarde | 345,716,560 |
Dividendpercentage | 0% |
52-weken bereik | 2.45 - 6.72 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Sean McClain |
Website | https://www.absci.com |
An error occurred while fetching data.
Over Absci Corporation
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)